| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |